How LDL Affects Multiple Myeloma: New Pathways to Keep Remission
Official title: Canonical and alternative functions of low-density lipoprotein in multiple myeloma
Funded at Univ of Arkansas for Med Scis · NIH-11444783 · Data updated 2026-11-12
A new grant is studying how cholesterol from LDL particles fuels multiple myeloma and how this interaction influences the tumor environment and immune response, with goals to help patients stay in remission.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | August 14, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $401,971 |
| NIH project number | 1R01CA299106-01A1 |
| Project ID | NIH-11444783 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with multiple myeloma or related blood cancers who could benefit from therapies targeting tumor metabolism and cholesterol pathways.
✕Less likely to help
Patients whose disease is driven by mechanisms unrelated to cholesterol or LDL uptake may not experience direct benefit.
What this research studies
This research looks at the role of LDL cholesterol in the bone marrow where multiple myeloma grows, exploring how cholesterol supply and cellular uptake affect tumor growth and treatment response. The project also examines how LDL can carry small RNAs that may change immune cells’ behavior in the tumor setting, which could open doors to new therapies. By studying these mechanisms in the lab, the team hopes to find strategies that make current treatments more durable and improve patient outcomes. The findings could guide future approaches to manage cholesterol-related factors in myeloma and related blood cancer conditions.
Why it matters
Potential benefit: If successful, the work could lead to new approaches that prolong remission and improve quality of life for people with multiple myeloma.
How similar studies have gone: Early studies have shown that LDL and cholesterol pathways can influence tumor biology and immune responses in some cancers, but this area remains exploratory.
Where this research is happening
-
Univ of Arkansas for Med Scis
Little Rock, United States Active
Researchers
- Principal investigator: Allen, Ryan M — Univ of Arkansas for Med Scis
- Study coordinator: Allen, Ryan M
Related research
Other NIH-funded projects on the same topics.
-
Integrative study of multiple myeloma genetics and disease biology
A team at Dana-Farber and partners is pursuing a long-term project to understand the genetic and molecular drivers of multiple myeloma and how treatments interact with disease biology.
-
Comparative Modeling to Prevent, Detect Early, and Treat Multiple Myeloma
A research team will build and compare computer models to understand how multiple myeloma develops, can be detected earlier, and treated more effectively.
-
Therapy-induced senescence and immune activation in multiple myeloma
A study in people with multiple myeloma will explore how treatment-related senescence in cancer cells may stimulate the immune system and affect cancer return after standard frontline therapy.
-
BCMA CAR-T enteritis: understanding immune toxicities in multiple myeloma
A broad study to uncover why some CAR-T cell treatments targeting BCMA cause severe intestinal inflammation in people with multiple myeloma.
-
Understanding Drug-Resistant Multiple Myeloma to Stop Relapse
Researchers are studying why some myeloma cells resist treatment and how to create new therapies to prevent relapse.
-
Overcoming resistance to CART cell therapy in multiple myeloma
This grant aims to improve CAR T-cell therapy for people with multiple myeloma by tackling why some patients stop responding, using innovative approaches to boost cancer-fighting cells in the bone marrow.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.